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Brooke–Spiegler syndrome (BSS), familial cylindromatosis (FC), and multiple familial trichoepithelioma (MFT),
originally described as distinct entities, share overlapping clinical ﬁndings. Patients with BSS are predisposed to
multiple skin appendage tumors such as cylindroma, trichoepithelioma, and spiradenoma. FC, however, is char-
acterized by cylindromas and MFT by trichoepitheliomas as the only tumor type. These disorders have recently
been associated with mutations in the CYLD gene. In this report, we describe three families with BSS, one with FC,
and two with MFT phenotypes associated with novel and recurrent mutations in CYLD. We provide evidence that
these disorders represent phenotypic variation of a single entity and lack genotype–phenotype correlation.
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Brooke–Spiegler syndrome (BSS, OMIM# 605041) (Brooke,
1892; Spiegler, 1899) is an autosomal dominantly inherited
disease characterized by multiple skin appendage tumors.
The predominating tumor can be a cylindroma, trichoe-
pithelioma, and/or spiradenoma. Although cylindromas and
spiradenomas are sweat gland tumors, trichoepitheliomas
show hair follicle differentiation. Therefore, it has been pos-
tulated that BSS results from defects in the regulation of
putative stem cells of the folliculo-sebaceous-apocrine unit,
giving rise to different skin appendage tumors (Fenske et al,
2000). Two autosomal dominantly inherited genoderma-
toses, familial cylindromatosis (FC, OMIM# 132700), and
multiple familial trichoepithelioma (MFT, OMIM# 601606),
have been originally described as distinct entities. FC, orig-
inally known as Ancell–Spiegler cylindromas, is character-
ized by cylindromas, whereas MFT, originally referred
to as Brooke–Fordyce trichoepitheliomas, is characterized
by trichoepitheliomas (Welch et al, 1968).
The gene for FC was mapped to chromosome 16q12–
q13 by linkage analysis (Biggs et al, 1995). The CYLD gene
was discovered by positional cloning and germline muta-
tions were identified in families with this disease (Bignell
et al, 2000). Loss of heterozygosity at the CYLD locus has
been found in both inherited and sporadic tumors, impli-
cating CYLD as a tumor suppressor gene (Bignell et al,
2000). Subsequently, mutations in CYLD in patients with
BSS phenotype were found (Hu et al, 2003). More recently,
CYLD has been identified as the susceptibility gene for
several families with MFT (Salhi et al, 2004; Zhang et al,
2004; Zheng et al, 2004). These findings, taken together
with the observations that features of BSS, FC, and MFT
can occur in the same patient or in different patients within a
single family (Gerretsen et al, 1995), and that a single CYLD
mutation can be associated with both cylindromas and
trichoepitheliomas (Poblete Gutierrez et al, 2002), suggest
that these syndromes not only share a common genetic ba-
sis but represent phenotypic variation of the same disease.
To date, there have been 29 germline mutations de-
scribed in the CYLD gene in families with BSS, FC, and MFT
(Bignell et al, 2000; Poblete Gutierrez et al, 2002; Hu et al,
2003; Scheinfeld et al, 2003; Salhi et al, 2004; Zhang et al,
2004; Zheng et al, 2004). In this report, we describe three
novel and two recurrent mutations in CYLD identified in five
unrelated families with BSS, FC, and MFT phenotypes.
Results
We evaluated three families with BSS, one with FC, and two
with MFT phenotypes (Table S1). The pedigree of each
family was consistent with an autosomal dominant mode of
inheritance (data not shown). In all families except one,
mutations in the CYLD gene were identified (Fig S1). These
mutations are summarized in Table S1. All of the identified
mutations were either nonsense or frameshift mutations re-
sulting in premature stop codons. The case in which a mu-
tation was not found (Cyld-3) showed an MFT phenotype
with multiple trichoepitheliomas as the only skin tumor.
Discussion
All of the reported mutations in CYLD have been het-
erozygous mutations with the majority (  90%) predicted
Abbreviations: BSS, Brooke–Spiegler syndrome; FC, familial
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to result in truncated proteins or lead to nonsense mediated
mRNA decay. To date, no mutations in the N-terminal region
of CYLD encoding the first two cytoskeletal-associated-
protein–glycine-concerved motifs have been reported (ex-
ons 4–8). The absence of mutations in the N-terminal region
encoding two CAP-GLY domains emphasizes the impor-
tance of these motifs for its function. The mutations, how-
ever, are scattered throughout the mid-portion and C-
terminal region. Although clustering of mutations in the C-
terminal region (exons 16–20) is noted (  60%), this is not
limited to one particular domain. As a result, for mutation
screening strategies, we recommend starting with exons
16–20 and then pursuing the other parts of the gene.
Of interest, in one of the cases described in this report
with the MFT phenotype (Cyld-3), we did not find sequence
alterations in the coding sequence and flanking introns of
CYLD. Although we cannot rule out the possibility of a large
germline deletion involving CYLD in this case, it is possible
that another locus for MFT exists. Evaluation of additional
families with MFT will help clarify the presence of genetic
heterogeneity.
In addition to tumors of the skin appendages, patients
with BSS are also at risk for developing tumors of the major
and minor salivary glands. Basal cell adenomas and adeno-
carcinomas of the parotid glands and minor salivary glands
have been reported in association with this disease (Jun-
gehulsing et al, 1999). One case described in this report
(Cyld-6) demonstrated bilateral parotid gland basal cell
adenocarcinomas, exemplifying this association.
We also evaluated the mutations in CYLD for genotype–
phenotype correlation. To date, there have been six muta-
tions described in association with the MFT phenotype.
These mutations located in exons 10, 15–18, and 20 show
no particular clustering in one region. Based on the current
mutational data in individuals with the BSS, FC, and MFT
phenotypes, in addition to the observation that within a
single family some individuals may have trichoepitheliomas
whereas others have cylindromas, it appears a correlation
between genotype and phenotype is lacking.
Materials and Methods
Six unrelated families with BSS, FC, or MFT phenotypes were re-
cruited to this study. The Institutional Review Board at Columbia
University approved all the described studies and the study was
conducted according to Declaration of Helsinki Guidelines. Blood
samples from affected individuals were collected after obtaining
informed consent. Genomic DNA was extracted from whole blood
using PureGene DNA isolation kit (Gentra Systems, Minneapolis,
Minnesota). The 17 coding exons of the CYLD gene were amplified
by PCR using specific primers. For mutation detection, the PCR
products were sequenced using an automated sequencing system
(310, Applied Biosystems, Foster City, California).
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